Pérez-Ríos Mónica, Schiaffino Anna, Montes Agustín, Fernández Esteve, López María José, Martínez-Sánchez José María, Sureda Xisca, Martínez Cristina, Fu Marcela, Continente Xavier García, Carretero José Luis, Galán Iñaki
Área de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.
Direcció General de Planificació en Salut, Departament de Salut, Generalitat de Catalunya; Grupo de Investigación en Control del Tabaco, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); Unidad de Control del Tabaco, Programa de Prevención y Control del Cáncer, Institut Català d'Oncologia (ICO).
Arch Bronconeumol. 2020 Sep;56(9):559-563. doi: 10.1016/j.arbr.2020.07.005. Epub 2020 Jul 18.
Smoking-attributable mortality (SAM) is a valuable indicator that can be used to characterize the course and health burden of the smoking epidemic. The aim of this paper was to estimate SAM in Spain in 2016 in the population aged 35 and over, using the best available evidence.
A smoking prevalence-dependent analysis based on the estimation of population-attributable fractions was performed. Smoking prevalence (never, former, and current smokers) was calculated from a combination of the Spanish Health Survey (2016) and the European Health Survey (2014); the relative risk of death among current and former smokers was taken from the follow-up of various cohorts; and mortality rates were obtained from National Center for Statistics data. SAM estimates are presented globally, and by sex, age groups, and major disease categories: cancer, cardiometabolic diseases and respiratory diseases.
In 2016, 56,124 deaths were attributed to tobacco consumption, 84% in men (47,000), and 50% in the population aged over 74 (27,795). Overall, 50% of SAM was due to cancer (28,281), 65% of which was lung cancer. One in 4 attributable deaths (13,849) occurred before the age of 65.
One in 7 deaths in Spain in 2016 were attributable to smoking. This estimation of SAM clearly highlights the great impact of smoking on mortality in Spain, mainly due to lung cancer and chronic obstructive pulmonary disease.
吸烟所致死亡率(SAM)是一项重要指标,可用于描述吸烟流行的过程和健康负担。本文旨在利用现有最佳证据,估算2016年西班牙35岁及以上人群的吸烟所致死亡率。
基于人群归因分数的估计进行了一项与吸烟流行率相关的分析。吸烟流行率(从不吸烟、曾经吸烟和当前吸烟者)通过结合西班牙健康调查(2016年)和欧洲健康调查(2014年)来计算;当前吸烟者和曾经吸烟者的相对死亡风险取自不同队列的随访数据;死亡率则从国家统计局数据中获取。吸烟所致死亡率的估计按总体、性别、年龄组以及主要疾病类别(癌症、心血管代谢疾病和呼吸系统疾病)进行呈现。
2016年,56,124例死亡归因于烟草消费,其中男性占84%(47,000例),74岁以上人群占50%(27,795例)。总体而言,50%的吸烟所致死亡率归因于癌症(28,281例),其中65%为肺癌。四分之一的归因死亡(13,849例)发生在65岁之前。
2016年西班牙七分之一的死亡归因于吸烟。吸烟所致死亡率的这一估计清楚地凸显了吸烟对西班牙死亡率的巨大影响,主要是由于肺癌和慢性阻塞性肺疾病。